Results 221 to 230 of about 34,322 (240)

Pharmacokinetics and concentration–effect relationship of adalimumab in rheumatoid arthritis

British Journal of Clinical Pharmacology, 2015
Hervé Watier, Gilles Paintaud, David Ternant   +2 more
exaly  

Adalimumab in active ulcerative colitis: A “real-life” observational study

Digestive and Liver Disease, 2013
Walter Fries, Silvio Danese, Daniela Pugliese   +2 more
exaly  

Comparative nonclinical assessments of the biosimilar PF-06410293 and originator adalimumab

Regulatory Toxicology and Pharmacology, 2020
Shawn P O’Neil
exaly  

Adalimumab

Reactions Weekly, 2008
openaire   +1 more source

Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome

Journal of Crohn's and Colitis, 2013
Joaquin Hinojosa DEL VAL, JOSÉ Luis Cabriada, Xavier Calvet   +2 more
exaly  

Adalimumab for Treatment of Noninfectious Uveitis

Ophthalmology, 2016
JOSÉ G Ruiz De Morales, MIGUEL Cordero-Coma   +1 more
exaly  

Adalimumab: a review of side effects

Expert Opinion on Drug Safety, 2005
Noah Scheinfeld
exaly  

Association Between Pharmacokinetics of Adalimumab and Mucosal Healing in Patients With Inflammatory Bowel Diseases

Clinical Gastroenterology and Hepatology, 2014
Xavier Roblin, Stéphane Paul, Hubert Marotte   +2 more
exaly  

Clinical experience with adalimumab biosimilar imraldi in hidradenitis suppurativa

Dermatologic Therapy, 2020
Antonella Di Cesare, Elia Rosi, Leonardo Pescitelli   +2 more
exaly  

Plasma trough levels of adalimumab and infliximab in terms of clinical efficacy during the treatment of psoriasis

Journal of Dermatology, 2013

exaly